These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3020038)

  • 1. Design of biologically active peptides with non-peptidic structural elements. Biological and physical properties of a synthetic analogue of beta-endorphin with unnatural amino acids in the region 6-12.
    Rajashekhar B; Kaiser ET
    J Biol Chem; 1986 Oct; 261(29):13617-23. PubMed ID: 3020038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and physical properties of a beta-endorphin analog containing only D-amino acids in the amphiphilic helical segment 13-31.
    Blanc JP; Kaiser ET
    J Biol Chem; 1984 Aug; 259(15):9549-56. PubMed ID: 6086639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the requirement for an amphiphilic helical structure in beta-endorphin through the design, synthesis, and study of model peptides.
    Blanc JP; Taylor JW; Miller RJ; Kaiser ET
    J Biol Chem; 1983 Jul; 258(13):8277-84. PubMed ID: 6305980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide models of dynorphin A(1-17) incorporating minimally homologous substitutes for the potential amphiphilic beta strand in residues 7-15.
    Taylor JW
    Biochemistry; 1990 Jun; 29(22):5364-73. PubMed ID: 1974458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW; Nguyen TM; Lemieux C; Maziak LA
    J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
    Taylor JW; Miller RJ; Kaiser ET
    Mol Pharmacol; 1982 Nov; 22(3):657-66. PubMed ID: 6296658
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-endorphin. Biological activity of analogs containing dermorphin and dynorphin sequences: ileum and vas deferens assays.
    Ho CL; Li CH
    Int J Pept Protein Res; 1987 Jan; 29(1):134-9. PubMed ID: 2883148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptor selectivity of peptide models of beta-endorphin.
    Taylor JW; Kaiser ET
    Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
    Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of beta-endorphin and analogues. Additional evidence for multiple opiate receptors.
    Lemaire S; Bérubé A; Derome G; Lemaire I; Magnan J; Regoli D; St Pierre S
    J Med Chem; 1978 Dec; 21(12):1232-5. PubMed ID: 214559
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of amino-terminal sequence of beta-endorphin and dynorphin in the determination of opiate receptor type selectivity.
    Chang JK; Chang KJ
    Life Sci; 1983; 33 Suppl 1():267-9. PubMed ID: 6141489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitability ot beta-endorphin, morphine and catecholamines of the vas deferens of the rat at different stages of development.
    Huidobro-Toro JP; Miranda H
    Eur J Pharmacol; 1981 Nov; 76(1):115-8. PubMed ID: 6274671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-endorphin: replacement of tyrosine in position 27 by tryptophan increases analgesic potency--preparation and properties of the 2-nitrophenylsulfenyl derivative.
    Li CH; Yamashiro D; Nicolas P
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1042-4. PubMed ID: 6280164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin.
    Cox BM; Ross M; Goldstein A; Palmour RM
    Brain Res; 1979 Apr; 165(2):311-9. PubMed ID: 217494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opiate activity of peptides derived from the three opioid peptide families on the rat vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM; Höllt V
    Neuropeptides; 1984 Dec; 5(1-3):181-4. PubMed ID: 6099492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive potencies of beta-casomorphin analogs as compared to their affinities towards mu and delta opiate receptor sites in brain and periphery.
    Brantl V; Pfeiffer A; Herz A; Henschen A; Lottspeich F
    Peptides; 1982; 3(5):793-7. PubMed ID: 6294635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-Endorphin. Interaction of synthetic analogs having different chain lengths with morphine and enkephalin receptors in rat brain membranes.
    Ferrara P; Li CH
    Int J Pept Protein Res; 1982 Mar; 19(3):259-62. PubMed ID: 6288588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-Endorphin. Synthesis and properties of double-headed and related analogs.
    Yamashiro D; Li CH; Nicolas P; Hammonds RG
    Int J Pept Protein Res; 1982 Apr; 19(4):348-53. PubMed ID: 6288593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide inhibitor of morphine- and beta-endorphin-induced analgesia.
    Lee NM; Friedman HJ; Leybin L; Cho TM; Loh HH; Li CH
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5525-6. PubMed ID: 6254086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.